glp-1 parkinson's disease lancet Are diabetes drugs like Ozempic coming for disease? — Parkinson Secrets GLP-1 Analogues in the Neurobiology

The letters are going out this week to tell people. Director of Benefits Strategy, large manufacturer Some focus group participants also said that GLP-1 agonist prescriptions for diabetics in their plans were increasing or were higher than they should be and suggested that enrollees who want the medication for weight loss were being diagnosed with diabetes even if they did not meet the criteria

More information Harvard Medical School has more on insurance coverage for GLP-1 drugs

Understanding the difference between insulin and GLP-1 agonists is step one

Despite these associations, catestatin has received limited attention as a therapeutic candidate, in part because it does not conform neatly to classical endocrine paradigms and lacks a single dominant receptor target

Back Kolata, G, Robbins, R (17 April 2025) 'Daily pill may work as well as Ozempic for weight loss and blood sugar', The New York Times

Bendotti, G